Long-Term Liabilities: The sum of all non-current liabilities.
Astria Therapeutics, Inc. (ATXS) had Long-Term Liabilities of $98.69M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-33.05M |
|
-- |
|
-- |
|
$35.82M |
|
$-35.82M |
|
$2.77M |
|
$-33.05M |
|
$-33.05M |
|
$-33.05M |
|
$-33.05M |
|
$-33.05M |
|
$-33.05M |
|
$-35.82M |
|
$-35.82M |
|
58.01M |
|
58.01M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$268.59M |
|
-- |
|
$13.34M |
|
$281.92M |
|
$18.04M |
|
-- |
|
|
Long-Term Liabilities |
$98.69M |
$116.73M |
|
$165.19M |
|
$165.19M |
|
$165.19M |
|
56.43M |
|
| Cash Flow Statement Financials | |
$-70.08M |
|
$86.58M |
|
$0.00M |
|
$59.82M |
|
$76.32M |
|
$16.50M |
|
$8.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-70.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.01% |
|
-20.01% |
|
-11.72% |
|
-20.01% |
|
$2.93 |
|
$-1.22 |
|
$-1.21 |
|